Moreover, the 36-month beta value for OPTN is -0.10. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OPTN is 80.41M and currently, short sellers hold a 4.00% of that float. On May 02, 2024, OPTN’s average trading volume was 1.07M shares.
OPTN) stock’s latest price update
OptiNose Inc (NASDAQ: OPTN)’s stock price has gone rise by 10.62 in comparison to its previous close of 0.82, however, the company has experienced a -1.85% decrease in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-04 that YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 10, 2024 at 2:15 p.m. ET.
OPTN’s Market Performance
OptiNose Inc (OPTN) has experienced a -1.85% fall in stock performance for the past week, with a -35.59% drop in the past month, and a -27.92% drop in the past quarter. The volatility ratio for the week is 15.73%, and the volatility levels for the past 30 days are at 10.52% for OPTN. The simple moving average for the past 20 days is -16.80% for OPTN’s stock, with a -29.45% simple moving average for the past 200 days.
Analysts’ Opinion of OPTN
Many brokerage firms have already submitted their reports for OPTN stocks, with H.C. Wainwright repeating the rating for OPTN by listing it as a “Buy.” The predicted price for OPTN in the upcoming period, according to H.C. Wainwright is $5 based on the research report published on March 11, 2024 of the current year 2024.
Lake Street, on the other hand, stated in their research note that they expect to see OPTN reach a price target of $3. The rating they have provided for OPTN stocks is “Buy” according to the report published on August 21st, 2023.
Jefferies gave a rating of “Buy” to OPTN, setting the target price at $5 in the report published on October 21st of the previous year.
OPTN Trading at -36.85% from the 50-Day Moving Average
After a stumble in the market that brought OPTN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.75% of loss for the given period.
Volatility was left at 10.52%, however, over the last 30 days, the volatility rate increased by 15.73%, as shares sank -34.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -33.22% lower at present.
During the last 5 trading sessions, OPTN fell by -1.85%, which changed the moving average for the period of 200-days by -2.34% in comparison to the 20-day moving average, which settled at $1.0679. In addition, OptiNose Inc saw -29.60% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPTN starting from Mahmoud Ramy A, who sale 19,198 shares at the price of $1.88 back on Mar 18 ’24. After this action, Mahmoud Ramy A now owns 1,331,278 shares of OptiNose Inc, valued at $36,092 using the latest closing price.
Marino Michael F III, the Chief Legal Officer & Corp Sec of OptiNose Inc, sale 15,059 shares at $1.88 during a trade that took place back on Mar 18 ’24, which means that Marino Michael F III is holding 602,268 shares at $28,311 based on the most recent closing price.
Stock Fundamentals for OPTN
Current profitability levels for the company are sitting at:
- -0.32 for the present operating margin
- 0.88 for the gross margin
The net margin for OptiNose Inc stands at -0.5. The total capital return value is set at 0.33.
Based on OptiNose Inc (OPTN), the company’s capital structure generated 2.92 points at debt to capital in total, while cash flow to debt ratio is standing at -0.16. The debt to equity ratio resting at -1.52. The interest coverage ratio of the stock is -1.16.
Currently, EBITDA for the company is -22.35 million with net debt to EBITDA at -2.57. When we switch over and look at the enterprise to sales, we see a ratio of 2.26. The receivables turnover for the company is 3.56for trailing twelve months and the total asset turnover is 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.60.
Conclusion
To wrap up, the performance of OptiNose Inc (OPTN) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
